Trial intelligence / Profile preview

Propofol vs Cipropofol for Perioperative Neurocognitive Disorders in Elderly Colorectal Cancer Surgery

ChiCTR2600117749Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of Inner Mongolia Medical University
Start
Jan 2026
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in perioperative neurocognitive disorder and postoperative delirium (POD) comparing Cipropofol + remifentanil with Propofol + remifentanil (2 arms). Primary endpoints: Postoperative delirium incidence rate and Incidence of delayed early postoperative neurocognitive recovery. Planned start Jan 2026; status: not yet recruiting.

02

Drugs

ciprofolpropofol
03

Conditions

perioperative neurocognitive disorderpostoperative delirium (POD)

Beyond the preview

Go deeper on ChiCTR2600117749.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2600117749.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call